(Q51080917)

29 March 2018

title

Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties. (English)

1 reference

29 March 2018

1 reference

Li Li

1

1 reference

29 March 2018

Sandeep Kumar

2

1 reference

29 March 2018

Patrick M Buck

3

1 reference

29 March 2018

Christopher Burns

4

1 reference

29 March 2018

Janelle Lavoie

5

1 reference

29 March 2018

Satish K Singh

6

1 reference

29 March 2018

Nicholas W Warne

7

1 reference

29 March 2018

Pilarin Nichols

8

1 reference

29 March 2018

Nicholas Luksha

9

1 reference

29 March 2018

Davin Boardman

10

1 reference

29 March 2018

publication date

7 June 2014

1 reference

29 March 2018

published in

Pharmaceutical Research

1 reference

29 March 2018

volume

31

1 reference

29 March 2018

issue

11

1 reference

29 March 2018

page(s)

3161-3178

1 reference

29 March 2018

Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Viscosity behavior of high-concentration protein mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Viscosity of concentrated therapeutic protein compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Protein aggregation and bioprocessing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Monoclonal antibody self-association, cluster formation, and rheology at high concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Polar solvents decrease the viscosity of high concentration IgG1 solutions through hydrophobic solvation and interaction: formulation and biocompatibility considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

High-throughput dynamic light scattering method for measuring viscosity of concentrated protein solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

High throughput thermostability screening of monoclonal antibody formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Design of therapeutic proteins with enhanced stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Impact of deglycosylation and thermal stress on conformational stability of a full length murine IgG2a monoclonal antibody: observations from molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Insights into the potential aggregation liabilities of the b12 Fab fragment via elevated temperature molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

On the role of aggregation prone regions in protein evolution, stability, and enzymatic catalysis: insights from diverse analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Establishing a link between amino acid sequences and self-associating and viscoelastic behavior of two closely related monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Increasing IgG concentration modulates the conformational heterogeneity and bonding network that influence solution properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Coarse-grained modeling of the self-association of therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

The role of amino acid sequence in the self-association of therapeutic monoclonal antibodies: insights from coarse-grained modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Proximity energies: a framework for understanding concentrated solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Exploring the sequence determinants of amyloid structure using position-specific scoring matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Influence of macromolecular crowding upon the stability and state of association of proteins: predictions and observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Structural Determinants of Unique Properties of Human IgG4-Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Antibody diffusion in human cervical mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Selective and specific ion binding on proteins at physiologically-relevant concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Effective charge measurements reveal selective and preferential accumulation of anions, but not cations, at the protein surface in dilute salt solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Very fast prediction and rationalization of pKa values for protein-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Graphical analysis of pH-dependent properties of proteins predicted using PROPKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Optimizing pKa computation in proteins with pH adapted conformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1409-0

Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations

21 January 2018

1 reference

12 December 2020

Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis

1 reference

12 December 2020

Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms

1 reference

12 December 2020

Assessment of net charge and protein-protein interactions of different monoclonal antibodies

1 reference

12 December 2020

Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions

1 reference

12 December 2020

Characterization and suitability of therapeutic antibody dense phases for subcutaneous delivery

1 reference

12 December 2020

Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability

1 reference

12 December 2020

Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design.

1 reference

12 December 2020

Computational methods to predict therapeutic protein aggregation

1 reference

12 December 2020

Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development

1 reference

12 December 2020

High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective.

1 reference

12 December 2020

Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects

1 reference

12 December 2020

Specific interactions in high concentration antibody solutions resulting in high viscosity

1 reference

12 December 2020

10.1007/S11095-014-1409-0

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018